Skip to content
stoqly

Agilent Technologies

A NYSE Life Sciences Tools & Services Financials FY2016–FY2025

Agilent Technologies' revenue rose 6.7% to $6.9 billion in fiscal 2025. Its operating margin was 21.3%, down from 22.9% a year earlier. Free cash flow was $1.2 billion, down 16.1%. It paid out $707 million in dividends and buybacks, 61% of free cash flow. The diluted share count fell 2.1%.

Last close · Oct 23, 2026

$173.07

0.5%
Value it Compare
Revenue Total sales reported in the income statement.
$6.9B
6.7% vs prior year
Operating margin Operating income as a share of revenue.
21.3%
1.6 pts
Net income Profit after all expenses, interest and tax.
$1.3B
1.1%
Free cash flow Cash from operations minus capital spending.
$1.2B
16.1%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
16.5%
0.4 pts
Market cap Last close times the latest diluted share count, so it is approximate.
$49.0B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
34.1x
On $5.07 EPS (TTM)

About these figures. Agilent's filings from fiscal 2023 tag a negative figure as its equity including minority owners' share, so its shareholders' equity is used throughout (Agilent has almost no minority owners).

What Agilent Technologies does

No business description yet.

Legal name
AGILENT TECHNOLOGIES, INC.
Fiscal year ends
October 31, 2025
Latest annual report
—
Accession · CIK
0001090872-25-000087
0001090872

Revenue and margins

Agilent Technologies had $6.9B of revenue in fiscal 2025, up 6.7% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

From fiscal 2016 to 2025, diluted EPS grew 14.0% a year. Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $1.2B in fiscal 2025, 16.6% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Agilent Technologies returned $707M to shareholders in fiscal 2025, 61% of free cash flow. The diluted share count fell 2.1%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Value Agilent Technologies yourself

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.

Discounted cash flow

Value per share

—

Adds net cash of −$1.6B and divides by 285.0M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Earnings multiple

Value per share

—

Reference multiples: today 34.1x · peers 44.0x · sector 27.9x.

Balance sheet

Cash, debt and the ratios that show how comfortably Agilent Technologies can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $1.5B$1.1B$1.6B$1.3B$1.8B
Debt incl. finance leases $2.7B$2.8B$2.7B$3.4B$3.4B
Net debt / EBITDA 0.8x0.9x0.7x1.2x0.9x
Debt / equity 0.5x0.5x0.5x0.6x0.5x
Interest coverage 16.6x19.3x14.2x15.5x13.2x
Current ratio 2.2x2.0x2.6x2.1x2.0x
Quick ratio 1.7x1.5x2.0x1.6x1.5x
Total assets $10.7B$10.5B$10.8B$11.8B$12.7B
Total liabilities $5.3B$5.2B$4.9B$5.9B$6.0B
Shareholders' equity $5.4B$5.3B$5.8B$5.9B$6.7B
Net debt (− = net cash) $1.2B$1.7B$1.1B$2.1B$1.6B

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$3.2M

3 insiders

Of sales under plans

63%

$2.0M

DateInsiderTradeSharesPriceValueFiling
Sep 4, 2026 Mikael DolstenDirector Sold 634 $151.38 $0.1M Form 4
May 29, 2026 Mikael DolstenDirector Sold 1,600 $135.42 $0.2M Form 4
Dec 1, 2025 Mikael DolstenDirector Sold 2,600 $149.81 $0.4M Form 4
Nov 26, 2025 Rodney GonsalvesV.p., Corporate Controller Sold 3,000 $154.99 $0.5M Form 4
Nov 18, 2025 Padraig McDonnellPresident and CEO, Director Sold plan 911 $143.24 $0.1M Form 4
Nov 12, 2025 Padraig McDonnellPresident and CEO, Director Sold plan 12,490 $150.00 $1.9M Form 4

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY23FY24FY25
Net income is positive ✓ ✓ ✓
Cash from operations is positive ✓ ✓ ✓
Return on assets rose ✓ ✓ ✕
Cash from operations exceeds net income ✓ ✓ ✓
Debt fell relative to assets ✓ ✕ ✓
Current ratio rose ✓ ✕ ✕
Share count didn't rise ✓ ✓ ✓
Gross margin rose ✕ ✓ ✕
Revenue rose relative to assets ✓ ✕ ✕
F-score 8 / 96 / 95 / 9
Accruals ratio −5.0%−4.1%−2.1%
Altman Z'' 3.903.233.48

Similar companies

Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
Agilent Technologies A $49.0B 6.7% 21.3% 16.6% 16.5% 34.1x 5
Avantor AVTR $11.7B −3.4% −3.8% 7.6% −2.1% — 5 Compare →
Illumina ILMN $41.2B −0.7% 18.6% 21.4% 20.3% 50.3x 8 Compare →
Mettler Toledo MTD $33.7B 4.0% — 21.1% 50.5% 37.6x 7 Compare →
Charles River Laboratories CRL $16.6B −0.9% 0.6% 12.9% 0.4% — 4 Compare →

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $4.2B $4.5B $4.9B $5.2B $5.3B $6.3B $6.8B $6.8B $6.5B $6.9B
Gross profit $2.2B $2.4B $2.7B $2.8B $2.8B $3.4B $3.7B $3.5B $3.5B $3.6B
Research and development $329M $341M $387M $404M $495M $441M $467M $481M $479M $455M
Operating income $615M $807M $904M $941M $846M $1.3B $1.6B $1.4B $1.5B $1.5B
Interest expense $72.0M $79.0M $75.0M $74.0M $78.0M $81.0M $84.0M $95.0M $96.0M $112M
Pretax income $859M $974M $946M $919M $842M $1.4B $1.5B $1.3B $1.5B $1.4B
Income tax $82.0M $119M $630M −$152M $123M $150M $250M $99.0M $232M $132M
Net income $462M $684M $316M $1.1B $719M $1.2B $1.3B $1.2B $1.3B $1.3B
Diluted EPS $1.40 $2.10 $0.97 $3.37 $2.30 $3.94 $4.18 $4.19 $4.43 $4.57
Diluted shares 0.33B 0.33B 0.33B 0.32B 0.31B 0.31B 0.30B 0.30B 0.29B 0.29B
Cash flow
Cash from operations $793M $889M $1.1B $1.0B $921M $1.5B $1.3B $1.8B $1.8B $1.6B
Capital expenditure $139M $176M $177M $155M $119M $188M $291M $298M $378M $407M
Free cash flow $654M $713M $910M $866M $802M $1.3B $1.0B $1.5B $1.4B $1.2B
Depreciation and amortization $246M $212M $210M $238M $308M $321M $317M $271M $257M $288M
Stock-based compensation $58.0M $60.0M $70.0M $72.0M $83.0M $110M $125M $111M $129M $128M
Acquisitions $261M $128M $516M $1.4B $0.0M $547M $52.0M $51.0M $862M $4.0M
Share buybacks $434M $194M $422M $723M $469M $788M $1.1B $575M $1.2B $425M
Dividends paid $150M $170M $191M $206M $222M $236M $250M $265M $274M $282M
Dividends and buybacks $584M $364M $613M $929M $691M $1.0B $1.4B $840M $1.4B $707M
Balance sheet
Cash and short-term investments $2.3B $2.7B $2.2B $1.4B $1.4B $1.5B $1.1B $1.6B $1.3B $1.8B
Total debt $1.9B $2.0B $1.8B $2.4B $2.4B $2.7B $2.8B $2.7B $3.4B $3.4B
Finance lease liabilities $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Current assets $3.6B $4.2B $3.8B $3.2B $3.4B $3.8B $3.8B $4.2B $4.0B $4.6B
Current liabilities $945M $1.3B $1.2B $2.1B $1.5B $1.7B $1.9B $1.6B $1.9B $2.3B
Inventory $533M $575M $638M $679M $720M $830M $1.0B $1.0B $972M $1.0B
Property and equipment, net $639M $757M $822M $850M $845M $945M $1.1B $1.3B $1.8B $2.0B
Total assets $7.8B $8.4B $8.5B $9.5B $9.6B $10.7B $10.5B $10.8B $11.8B $12.7B
Total liabilities $3.5B $3.6B $4.0B $4.7B $4.8B $5.3B $5.2B $4.9B $5.9B $6.0B
Shareholders' equity $4.2B $4.8B $4.6B $4.7B $4.9B $5.4B $5.3B $5.8B $5.9B $6.7B
Margins
Gross margin 52.3% 53.9% 54.5% 54.3% 53.1% 53.9% 54.4% 50.7% 54.3% 52.4%
Operating margin 14.6% 18.1% 18.4% 18.2% 15.9% 21.3% 23.6% 19.8% 22.9% 21.3%
EBITDA margin 20.5% 22.8% 22.7% 22.8% 21.6% 26.4% 28.3% 23.7% 26.8% 25.4%
Net margin 11.0% 15.3% 6.4% 20.7% 13.5% 19.2% 18.3% 18.2% 19.8% 18.8%
FCF margin 15.6% 15.9% 18.5% 16.8% 15.0% 20.5% 14.9% 21.6% 21.1% 16.6%
Returns
Return on capital 14.5% 17.7% 10.9% 19.0% 12.5% 19.3% 19.8% 17.9% 16.9% 16.5%
Return on capital employed 9.2% 11.5% 12.4% 12.8% 10.9% 15.7% 18.3% 15.1% 15.6% 14.6%
Return on equity 11.0% 15.1% 6.7% 23.0% 15.0% 23.6% 23.5% 22.2% 22.0% 20.6%
Return on assets 6.1% 8.4% 3.7% 11.9% 7.5% 11.9% 11.8% 11.7% 11.4% 10.6%
Growth
Revenue growth 4.1% 6.4% 9.9% 5.1% 3.4% 18.4% 8.4% −0.2% −4.7% 6.7%
Net income growth 15.2% 48.1% −53.8% 238.9% −32.9% 68.3% 3.6% −1.1% 4.0% 1.1%
EPS growth 16.7% 50.0% −53.8% 247.4% −31.8% 71.3% 6.1% 0.2% 5.7% 3.2%
FCF growth 58.0% 9.0% 27.6% −4.8% −7.4% 61.7% −21.3% 44.4% −6.9% −16.1%
Share count change −1.8% −0.9% −0.3% −2.2% −1.9% −1.6% −2.3% −1.3% −1.7% −2.1%
Financial health
Net debt / EBITDA −0.5x −0.7x −0.4x 0.9x 0.8x 0.8x 0.9x 0.7x 1.2x 0.9x
Debt / equity 0.5x 0.4x 0.4x 0.5x 0.5x 0.5x 0.5x 0.5x 0.6x 0.5x
Interest coverage 8.5x 10.2x 12.1x 12.7x 10.9x 16.6x 19.3x 14.2x 15.5x 13.2x
Current ratio 3.9x 3.3x 3.3x 1.5x 2.3x 2.2x 2.0x 2.6x 2.1x 2.0x
Quick ratio 3.3x 2.9x 2.7x 1.2x 1.8x 1.7x 1.5x 2.0x 1.6x 1.5x
Capital allocation
Capex / revenue 3.3% 3.9% 3.6% 3.0% 2.2% 3.0% 4.3% 4.4% 5.8% 5.9%
Stock comp / revenue 1.4% 1.3% 1.4% 1.4% 1.6% 1.7% 1.8% 1.6% 2.0% 1.8%
Payouts / FCF 89.3% 51.1% 67.4% 107.3% 86.2% 79.0% 136.0% 57.0% 103.7% 61.4%
Quality scores
Piotroski F-score 8.0 8.0 7.0 5.0 6.0 7.0 6.0 8.0 6.0 5.0
Altman Z'' 6.6 4.3 3.9 2.5 3.0 3.3 3.4 3.9 3.2 3.5
Accruals ratio −4.3% −2.5% −9.1% 0.6% −2.1% −2.7% −0.6% −5.0% −4.1% −2.1%

Source: SEC EDGAR XBRL filings (CIK 0001090872). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move · ↵ to open